Mad Money w/ Jim Cramer 6/12/24
Mad Money w/ Jim Cramer
00:00
Strategic Shifts and Acquisitions in Novartis
The chapter explores Novartis' recent strategic moves in the pharmaceutical industry, including restructuring, acquisitions, and refocusing on cancer immunology. It discusses the company's financial performance, patent challenges, and positive outlook under new leadership.
Play episode from 14:02
Transcript
